High Risk Muscle Invasive Bladder Cancer clinical trials

Explore recruiting high risk muscle invasive bladder cancer clinical trials.

Recruiting high risk muscle invasive bladder cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Muscle Invasive Bladder Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Double-blind, Multicenter, Randomized study of Atezolizumab (anti-PD‑L1 antibody) versus Placebo as Adjuvant therapy in Patients with High-Risk Muscle-Invasive Bladder Cancer who are CTDNA positive following cystectomy

Germany, Greece, Ireland, Spain, Poland, Czechia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Risk Muscle Invasive Bladder Cancer trials by city

High Risk Muscle Invasive Bladder Cancer in Toronto High Risk Muscle Invasive Bladder Cancer in Vancouver High Risk Muscle Invasive Bladder Cancer in Montreal High Risk Muscle Invasive Bladder Cancer in Calgary High Risk Muscle Invasive Bladder Cancer in Edmonton High Risk Muscle Invasive Bladder Cancer in Ottawa High Risk Muscle Invasive Bladder Cancer in Winnipeg High Risk Muscle Invasive Bladder Cancer in Quebec City High Risk Muscle Invasive Bladder Cancer in Hamilton High Risk Muscle Invasive Bladder Cancer in Kitchener High Risk Muscle Invasive Bladder Cancer in London High Risk Muscle Invasive Bladder Cancer in Halifax High Risk Muscle Invasive Bladder Cancer in New York High Risk Muscle Invasive Bladder Cancer in Los Angeles High Risk Muscle Invasive Bladder Cancer in Chicago High Risk Muscle Invasive Bladder Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease